Not applicableStudy completedNCT01918267
What this trial is testing
U-Act-After: An Observational Study on Long-Term Efficacy of Tight Control RoActemra/Actemra (Tocilizumab) and/or Methotrexate in Patients With Early Rheumatoid Arthritis Who Have Participated in the U-Act-Early Study (ML22497)
Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 226